Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey

NCT04304456 is registered in ClinicalTrials.gov with SCARE (Study group for carbapenem resistance) as lead sponsor.

NCT NCT04304456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04304456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey
Lead sponsor
SCARE (Study group for carbapenem resistance)
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2020
Completion date
April 30, 2022
Enrollment
810 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, hospital acquired condition, sepsis